Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Tectonic Therapeutic has raised $185.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.
Tectonic Therapeutic's investors include Vida Ventures, Polaris Partners, Adage Capital Management, 5AM Ventures, Soleus Capital.
Tectonic Therapeutic is headquartered in Watertown, United States.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Tectonic Therapeutic is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tectonic Therapeutic — Funding & Investors." VCBacked, February 3, 2025, https://www.vcbacked.co/company/tectonic-therapeutic. Accessed September 29, 2026.
VCBacked. (2025). Tectonic Therapeutic — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/tectonic-therapeutic
{{cite web |title=Tectonic Therapeutic — Funding & Investors |url=https://www.vcbacked.co/company/tectonic-therapeutic |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated